Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
Conventional cancer cell lines and animal models have been mainstays of cancer research.More recently, human pluripotent stem cells (hPSCs) and hPSC-derived organoid technologies, together with genome Myo-Inositol engineering approaches, have provided a complementary platform to model cancer progression.Here, we review the application of these tech